The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patients.

The use of betrixaban for extended prophylaxis of venous thromboembolism events in hospitalized, high-risk patients. Am J Manag Care. 2018 Nov;24(22 Suppl):S475-S482 Authors: Dobesh PP, Ahuja T, Davis GA, Fatodu H, Francis WH, Hull FP, Johnson GL, Lenchus JD, Lenoir JG, McPherson C, Nemeth J, Riello RJ Abstract PMID: 30452199 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30452199?dopt=Abstract

Source: The American Journal of Managed Care - November 1, 2018 Category: Health Management Authors: Dobesh PP, Ahuja T, Davis GA, Fatodu H, Francis WH, Hull FP, Johnson GL, Lenchus JD, Lenoir JG, McPherson C, Nemeth J, Riello RJ Tags: Am J Manag Care Source Type: research

More News: Health Management | Managed Care | Thrombosis